The Pill-osophy of Making Medicines Safe

Moderator(s)

• 

  Hubert Leufkens, PhD, FISPE

  Emeritus Professor
  University of Utrecht
  Woerden, Netherlands
• 

  Jieni Li, MPH, PhD

  Postdoctoral Fellow
  University of Houston, College of Pharmacy, Department of Pharmaceutical Health Outcomes and Policy
  Houston, United States

Presentations:

• 1:00 PM – 1:15 PM CEST

  Bleeding risk associated with non-steroidal anti-inflammatory drug use in patients with venous thromboembolism: a nationwide cohort study
  

  Presenting Author: Søren Riis Petersen, BSc – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital

  Co-Author: Kasper Bonnesen, MD, PhD (he/him/his) – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital

  Co-Author: Lars Pedersen, MSc, PhD – Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital

  Co-Author: Erik Lerkevang Grove, MD, PhD – Department of Cardiology, Aarhus University Hospital

  Co-Author: Morten Schmidt, MD, PhD, DMSc – The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital
• 1:15 PM – 1:30 PM CEST

  Prescribed drug use and aneurysmal subarachnoid haemorrhage incidence: A drug-wide association study
  

  Presenting Author: Shahab Abtahi, MD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University

  Co-Author: Jos P. Kanning – University Medical Center Utrecht

  Co-Author: Christian Schnier – The University of Edinburgh

  Co-Author: Olaf H. Klungel, PharmD, PhD – Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University

  Co-Author: Mirjam I. Geerlings, PhD – Amsterdam UMC, department of General Practice

  Co-Author: Ynte M. Ruigrok, MD, PhD – UMC Utrecht
• 1:30 PM – 1:45 PM CEST

  Comparison of switching to direct oral anticoagulants and continuous low-molecular-weight heparin in the treatment of cancer-associated venous thromboembolism in Taiwan
  

  Presenting Author: Wei Kang, MSc – The University of Hong Kong

  Co-Author: Chin-Yao Shen, MClinPharm – School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

  Co-Author: Michael Chun-Yuan Cheng, MA (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

  Co-Author: Vincent KC Yan, BPharm – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong

  Co-Author: Yue Wei, MPH – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong

  Co-Author: Tung Hiu Li, MPhil – Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR

  Co-Author: Caige Huang – Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, University of Hong Kong

  Co-Author: Edward Chia-Cheng Lai, PhD (he/him/his) – Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Taiwan

  Co-Author: Ian Chi Kei Wong, PhD (he/him/his) – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong

  Co-Author: Esther W Chan, PhD – Centre for Safe Medication Practice and research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong
• 1:45 PM – 2:00 PM CEST

  Conjunctivitis Among Individuals with Moderate-to-Severe Atopic Dermatitis Treated with Dupilumab in the United States
  

  Presenting Author: Jessica M. Franklin, PhD (she/her/hers) – Optum

  Co-Author: Andrea F. Marcus, PhD, MPH (she/her/hers) – Regeneron Pharmaceuticals

  Co-Author: Ihtisham Sultan, Ph.D – Regeneron

  Co-Author: Ashley Howell – Regeneron

  Co-Author: Sarah-Jo Sinnott, MPharm, PhD – Sanofi

  Co-Author: Jeannette Green – Regeneron

  Co-Author: Stephen M. Ezzy, MS – Optum

  Co-Author: Robert Gately – Optum

  Co-Author: Rachel E. E. Sobel, DrPH (she/her/hers) – Regeneron

  Co-Author: Florence Wang, ScD – Optum
• 2:00 PM – 2:15 PM CEST

  Post-Surgical Opioid Initiation and Diverticulitis Risk: a Multi-jurisdictional Population-Based Cohort Study
  

  Presenting Author: Michael Andrew Webster-Clark, PharmD, PhD (he/him/his) – McGill University

  Co-Author: Matthew Dahl – Manitoba Centre for Health Policy

  Co-Author: Amani Hamad – Manitoba Centre for Health Policy

  Co-Author: Michael Paterson – Institute for Clinical Evaluation Sciences

  Co-Author: Fangyun Wu – Institute for Clinical Evaluation Sciences

  Co-Author: Carolina Moriello – Lady Davis Institute of the Jewish General Hospital

  Co-Author: Audray St-Jean – Lady Davis Institute of the Jewish General Hospital

  Co-Author: Samy Suissa, PhD, FRSC, FCAHS – McGill University

  Co-Author: Robert W. Platt, PhD (he/him/his) – McGill University
• 2:15 PM – 2:30 PM CEST

  Pharmacogenetic CYP2D6 variability, phenoconversion and treatment outcomes: A Danish population-based cohort study of 6,798 individuals initiating atomoxetine treatment
  

  Presenting Author: Christiane Gasse, PhD, Dip Epid (McGill) – Aarhus University Hospital Psychiatry

  Co-Author: Kazi Ishtiak-Ahmed – Department of Affective Disorders, Aarhus University Hospital Psychiatry, Aarhus, Denmark

  Co-Author: Janne Pia Thistrup – Aarhus University

  Co-Author: Loa Clausen – Aarhus University Hospital

  Co-Author: Per Hove Thomsen – Aarhus University Hospital Psychiatry